Company: IMCR
Filing Date: 2025-04-04
Form Type: DEF 14A
Source: 0001140361-25-012123
Chunk: 115

Company: Immunocore Holdings plc
Filing Date: 2025-04-04
Form: DEF 14A
Chunk 115
---
 Vesting may be accelerated in certain circumstances, such as in connection with a change of control.                                                                                                                                                                                              
 Non-Executive Directors may also hold awards granted under the predecessor plans to the EIP and may also participate in any future discretionary equity incentive plan that may be adopted from time to time to replace the EIP.                                                                                                                                                                                                                                                                                                                                                                                      |
| Maximum opportunity                   |     | There is no maximum number of equity incentive awards that may be awarded to individuals each year. However, when reviewing award levels, account is taken of market movements in equity incentive awards, Board committee responsibilities, ongoing time commitments and the general economic environment.                                                                                                                                                                                                                                                                                                           |
| Performance-related framework         |     | Performance Awards will not be made to Non-Executive Directors. However, we believe share options are inherently performance-based and automatically link pay to shareholder return, as the value realized, if any, from an award of share options is dependent upon, and directly proportionate to, future appreciation in our share price.                                                                                                                                                                                                                                                                          |

Non-Executive Directors’ Terms of Engagement – Letters of Appointment The Company has entered into appointment letters with its Non-Executive Directors. The terms of appointment for a new Non-Executive Director would be in accordance with the Remuneration Policy for Non-Executive Directors as set out in the policy table above. Newly appointed Non-Executive Directors would normally receive an initial

A-14

TABLE OF CONTENTS

award of market value options (but this may also take the form of restricted share units or similar securities) on the date of election or appointment, which will vest based on time only on a monthly basis over a three-year period from the date of grant, provided that the Non-Executive Director continues his or her directorship through each of the vesting dates. A Non-Executive Director’s directorship may be terminated at any time by the Non-Executive Director or the Board giving one month’s notice in writing, or by the Company in accordance with Company Articles.

| Non-Executive Directors       |     | Date of appointment letter |     | Date of appointment |     | Date of Resignation |
| Professor Sir John Bell       |     | February 2021              |     | 7 January 2021      |     | —                   |
| Kristine Peterson             |     | February 2021              |     | 22 January 2021     |     | —                   |
| Robert Perez                  |     | February 2021              |     | 22 January 2021     |     | —                   |